New research published in the Journal of Psychopathology and Clinical Science suggests that how quickly and frequently we ...
Some of today’s most capable AI systems are refined versions of large language models (LLMs) that predict text on the basis ...
The study, published in the Journal of the American Medical Association, or JAMA, on Oct. 13, found that 9- to 13-year-olds ...
A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...
During his two-year search, Moody and the nonprofit Alzheimer’s Los Angeles began working with L.A. County Supervisor Janice ...
The burden of cognitive decline is growing, affecting many people worldwide and placing a substantial strain on health-care ...
Background: Spatial abilities are essential cognitive skills for many aspects of our everyday life that develop substantially throughout childhood and adolescence. While there are numerous measurement ...
Quitting smoking during midlife or even later on can help slow down age-related cognitive decline, a new study suggests ...
The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier assessment and diagnosis.
The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback